Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke
Main Author: | |
---|---|
Publication Date: | 2023 |
Other Authors: | , , |
Format: | Article |
Language: | por |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | https://doi.org/10.24950/rspmi.1602 |
Summary: | Introduction: The stroke prevention strategy in patients with intracerebral hemorrhage (ICH) and atrial fibrillation (AF) is a clinical dilemma. The aim of this study was to evaluate themanagement of anticoagulation therapy in patients with AFand admitted with ICH. Methods: We performed a descriptive analysis of patientsadmitted for ICH from 2009 to 2021. Data collection was carried out by consulting the processes and analyzing demographic, clinical and imaging data, and prior and post-discharge therapy. A comparative analysis of outcomes of anticoagulant therapy was performed between direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). Results: A total of 28 patients (22 male patients; median age 75 years) were included in the study, of which 19 were previously on anticoagulation therapy. Only eight (re)startedanticoagulation after discharge. There were 19 deaths, of which 17 were in the group without post-discharge anticoagulation; of those, five occurred in the first month after ICH. Discussion: There was strong concordance between BFFA and culture for detection of bacteria. In fact, most bacteria (76/106 [72%]) detected by BFFA were also identified in culture. In other hand, it is relevant that only one negative BFPP had an isolated agent in the cultural exam. Conclusion: Most patients did not (re)initiate anticoagulationafter ICH, despite being a high-risk group for new cerebrovascular events, which makes the discussion on this topic evenmore relevant. There was a change in the prescription pattern from VKAs to DOACs, comparing the two periods analyzed. |
id |
RCAP_de7ac1f88faf74ffdb9752ba58a3d500 |
---|---|
oai_identifier_str |
oai:oai.revista.spmi.pt:article/1602 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic StrokeHipocoagulação em Doentes com Fibrilhação Auricular e Internados por AVC HemorrágicoAcidente Vascular Cerebral HemorrágicoAnticoagulantesFibrilação AuricularAnticoagulantsAtrial FibrillationHemorrhagic StrokeIntroduction: The stroke prevention strategy in patients with intracerebral hemorrhage (ICH) and atrial fibrillation (AF) is a clinical dilemma. The aim of this study was to evaluate themanagement of anticoagulation therapy in patients with AFand admitted with ICH. Methods: We performed a descriptive analysis of patientsadmitted for ICH from 2009 to 2021. Data collection was carried out by consulting the processes and analyzing demographic, clinical and imaging data, and prior and post-discharge therapy. A comparative analysis of outcomes of anticoagulant therapy was performed between direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). Results: A total of 28 patients (22 male patients; median age 75 years) were included in the study, of which 19 were previously on anticoagulation therapy. Only eight (re)startedanticoagulation after discharge. There were 19 deaths, of which 17 were in the group without post-discharge anticoagulation; of those, five occurred in the first month after ICH. Discussion: There was strong concordance between BFFA and culture for detection of bacteria. In fact, most bacteria (76/106 [72%]) detected by BFFA were also identified in culture. In other hand, it is relevant that only one negative BFPP had an isolated agent in the cultural exam. Conclusion: Most patients did not (re)initiate anticoagulationafter ICH, despite being a high-risk group for new cerebrovascular events, which makes the discussion on this topic evenmore relevant. There was a change in the prescription pattern from VKAs to DOACs, comparing the two periods analyzed.Introdução: A estratégia de prevenção secundária em doentes com acidente vascular cerebral hemorrágico (AVCh) e fibrilhação auricular (FA) é um dilema clínico. O objetivo dos autores foi avaliar a introdução ou manutenção de terapêutica hipocoagulante em doentes com FA e internados por AVCh. Métodos: Análise descritiva dos doentes internados por AVCh de 2009 a 2021. Foi feita a colheita de dados pelaconsulta dos processos e analisados dados demográficos, clínicos, imagiológicos e a terapêutica prévia e após alta.Realizou-se uma análise comparativa da terapêutica hipocoagulante entre anticoagulantes orais diretos (DOAC) e antagonistas da vitamina K (AVK). Resultados: Este estudo incluiu 104 pacientes, com idade média de 62 anos. O BFFA foi positivo em 111/125 (88%) dasamostras colhidas. As bactérias mais comummente detetadas foram Staphylococcus aureus (19%), Klebsiella pneumonia (14%) e Haemophilus influenza (10%). Discussão: Um total de 28 doentes (22 do género masculino; mediana de idade de 75 anos) foram incluídos no estudo, dos quais 19 eram hipocoagulados previamente. Destes, oito (re)iniciaram a hipocoagulação após a alta. Verificou-se o óbito em 19 doentes, dos quais 17 pertenciam ao grupo sem hipocoagulação após alta e destes, cinco óbitos foram verificados no primeiro mês após o AVCh. Conclusão: A maioria dos doentes não (re)iniciou hipocoagulação após AVCh, apesar de serem um grupo de alto risco para novos eventos cerebrovasculares, o que torna a discussão sobre este tema ainda mais relevante. Assistiu-se a uma mudança no padrão de prescrição de AVK para DOAC, comparando os dois períodos em análise.Sociedade Portuguesa de Medicina Interna2023-12-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.24950/rspmi.1602https://doi.org/10.24950/rspmi.1602Internal Medicine; Vol. 30 No. 4 (2023): Outubro/Dezembro; 216-221Medicina Interna; Vol. 30 N.º 4 (2023): Outubro/Dezembro; 216-2212183-99800872-671Xreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://revista.spmi.pt/index.php/rpmi/article/view/1602https://revista.spmi.pt/index.php/rpmi/article/view/1602/1836Direitos de Autor (c) 2023 Medicina Internainfo:eu-repo/semantics/openAccessSantos, Maria BeatrizRodrigues, AlexandraFerreira, PatríciaPaiva Nunes, Ana2023-12-16T06:15:47Zoai:oai.revista.spmi.pt:article/1602Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T11:48:55.475204Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke Hipocoagulação em Doentes com Fibrilhação Auricular e Internados por AVC Hemorrágico |
title |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke |
spellingShingle |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke Santos, Maria Beatriz Acidente Vascular Cerebral Hemorrágico Anticoagulantes Fibrilação Auricular Anticoagulants Atrial Fibrillation Hemorrhagic Stroke |
title_short |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke |
title_full |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke |
title_fullStr |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke |
title_full_unstemmed |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke |
title_sort |
Hipocoagulation in Patients with Atrial Fibrillation and Admitted for Hemorrhagic Stroke |
author |
Santos, Maria Beatriz |
author_facet |
Santos, Maria Beatriz Rodrigues, Alexandra Ferreira, Patrícia Paiva Nunes, Ana |
author_role |
author |
author2 |
Rodrigues, Alexandra Ferreira, Patrícia Paiva Nunes, Ana |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Santos, Maria Beatriz Rodrigues, Alexandra Ferreira, Patrícia Paiva Nunes, Ana |
dc.subject.por.fl_str_mv |
Acidente Vascular Cerebral Hemorrágico Anticoagulantes Fibrilação Auricular Anticoagulants Atrial Fibrillation Hemorrhagic Stroke |
topic |
Acidente Vascular Cerebral Hemorrágico Anticoagulantes Fibrilação Auricular Anticoagulants Atrial Fibrillation Hemorrhagic Stroke |
description |
Introduction: The stroke prevention strategy in patients with intracerebral hemorrhage (ICH) and atrial fibrillation (AF) is a clinical dilemma. The aim of this study was to evaluate themanagement of anticoagulation therapy in patients with AFand admitted with ICH. Methods: We performed a descriptive analysis of patientsadmitted for ICH from 2009 to 2021. Data collection was carried out by consulting the processes and analyzing demographic, clinical and imaging data, and prior and post-discharge therapy. A comparative analysis of outcomes of anticoagulant therapy was performed between direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs). Results: A total of 28 patients (22 male patients; median age 75 years) were included in the study, of which 19 were previously on anticoagulation therapy. Only eight (re)startedanticoagulation after discharge. There were 19 deaths, of which 17 were in the group without post-discharge anticoagulation; of those, five occurred in the first month after ICH. Discussion: There was strong concordance between BFFA and culture for detection of bacteria. In fact, most bacteria (76/106 [72%]) detected by BFFA were also identified in culture. In other hand, it is relevant that only one negative BFPP had an isolated agent in the cultural exam. Conclusion: Most patients did not (re)initiate anticoagulationafter ICH, despite being a high-risk group for new cerebrovascular events, which makes the discussion on this topic evenmore relevant. There was a change in the prescription pattern from VKAs to DOACs, comparing the two periods analyzed. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-12-15 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.24950/rspmi.1602 https://doi.org/10.24950/rspmi.1602 |
url |
https://doi.org/10.24950/rspmi.1602 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revista.spmi.pt/index.php/rpmi/article/view/1602 https://revista.spmi.pt/index.php/rpmi/article/view/1602/1836 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2023 Medicina Interna info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2023 Medicina Interna |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Medicina Interna |
dc.source.none.fl_str_mv |
Internal Medicine; Vol. 30 No. 4 (2023): Outubro/Dezembro; 216-221 Medicina Interna; Vol. 30 N.º 4 (2023): Outubro/Dezembro; 216-221 2183-9980 0872-671X reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833592263822802944 |